The transition from accelerated to traditional approval is backed by robust 24-month eGFR data from the phase 3 APPLAUSE-IgAN trial.
Hypoactive sexual desire disorder is a common, underrecognized condition in women that arises from neurologic, hormonal, and ...
A presentation at AANP 2026 highlights the role of primary care nurse practitioners in screening older patients for geriatric ...
BC, presented ways in which artificial intelligence (AI) can be part of the solution to widespread burnout among NPs. Dr ...
Researchers analyzed the impact of disease control and cumulative glucocorticoid exposure on muscle mass preservation in rheumatoid arthritis.
Many nurse practitioners operating under restricted practice authority experience little to no face-to-face interaction or ...
Clinical Advisor Director Nikki Kean sat down with Dr Fuller at the American Association of Nurse Practitioners (AANP) annual conference in Las Vegas, Nevada.
Drivers of uncertainty include symptom confusion and attribution, knowledge gaps, and barriers to confirmation and care ...
Researchers examined the effect of biologic therapy use on incident psoriatic arthritis among patients with psoriasis.
Chronic pain and cancer pain management require a multimodal approach that addresses physical, emotional, and spiritual ...
Millions of residents across the Midwest and Northeast experience dangerous air conditions driven by dense, fast-moving Canadian and Minnesota wildfire smoke.
Topline data from the phase 3 E-BEOND and C-BEOND trials show a significant reduction in monthly migraine days at 24 weeks, demonstrating efficacy across the full migraine spectrum.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results